Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients

Mayo Clinic Proceedings Innovations Quality & Outcomes(2020)10.1016/j.mayocpiqo.2020.06.005Source: DataRank Database

Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients is a research paper published in Mayo Clinic Proceedings Innovations Quality & Outcomes (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.05)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Rae Wannier ORCID,David J. Sterken,Margaret C. Fang ORCID,Jeffrey L. Wolf ORCID,Priya A. Prasad ORCID

Live enrichment

PubMed:33367215 PMC:PMC7749233 OpenAlex:https://openalex.org/W3094758678

National Institutes of Health

Grant: K24HL141354

National Institutes of Health

Grant: 5K24HL141354-04

Use and outcomes of anticoagulants for the treatment and prevention of thrombosis among hospitalized patients

National Heart, Lung, and Blood Institute

University of California, San Francisco

FWCI

0.05

Citation Percentile

0.5%

Citation Trend

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.mayocpiqo.2020.06.005

publisherhttps://doi.org/10.1016/j.mayocpiqo.2020.06.005

publisherhttps://api.elsevier.com/content/article/PII:S2542454820301077?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2542454820301077?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33367215

Fields of Study

Clostridium difficile and Clostridium perfringens researchNosocomial Infections in ICUAntibiotic Use and Resistance03 medical and health sciences0302 clinical medicine

Keywords

MedicineInternal medicineIncidence (geometry)HematologyAdverse effectOdds ratioCohort studyClostridioidesRr, Relative RiskUcsf, University Of California, San FranciscoEhr, Electronic Health RecordIdsa, Infectious Disease Society Of AmericaAa, Antimotility AgentIcd-10, International Statistical Classification Of Diseases, Tenth RevisionHsct, Hematopoietic Stem Cell TransplantIcd-9, International Classification Of Diseases, Ninth RevisionCdi, Clostridioides Difficile InfectionMedicine (General)R5-920Original Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients

FAIR Checklist

Authors (6)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)